Ibudilast slows down brain shrinkage in patients with progressive multiple sclerosis |
Journal Updates
eMediNexus Coverage from: 
Ibudilast slows down brain shrinkage in patients with progressive multiple sclerosis

0 Read Comments                

Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The findings of the study are published August 29, 2018 in the New England Journal of Medicine. The main side effects observed were headaches and gastrointestinal.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now